IRCCS Centro di Riferimento Oncologico della Basilicata: Difference between revisions

From Beacon
Line 63: Line 63:
'''Access Information:''' Information [https://www.crob.it/per-pazienti-e-visitatori/informazioni-accoglienza/associazioni/].
'''Access Information:''' Information [https://www.crob.it/per-pazienti-e-visitatori/informazioni-accoglienza/associazioni/].


=== Associations ===
=== Associations List ===


'''Primary purpose:''' To provide support, information, and a sense of community for individuals undergoing cancer treatment. There are several active associations in the institute.
'''Primary purpose''': The website provides a list of the active patient associations in the hospital.


'''Access Information:''' Information [https://www.crob.it/per-pazienti-e-visitatori/informazioni-accoglienza/associazioni/].
'''Access Information:''' Information [https://www.crob.it/per-pazienti-e-visitatori/informazioni-accoglienza/associazioni/].
</div>
</div>

Revision as of 14:49, 15 September 2023

Experts

Learning Resources

Training: Trainings and Events

Primary purpose: To enhance professional, organizational, and relational culture for both individuals and the collective through training and updating activities.

Target audience: Staff who work within the IRCCS CROB.

Access Information: Information [1].

Cancer-related Patient Associations and Resources

Resource: Publications for patients

Primary purpose: To offer guides, publications, and a service card, where the patient will find all the information useful for your orientation in the Institute.

Access Information: Service card [2], Institute guides [3] and other publications [4].

Facility: Religious Assistance

Primary purpose: To provide a place for Catholic religious services and support for patients, with information and contact details available in the chapel.

Access Information: Information [5].

Associations List

Primary purpose: The website provides a list of the active patient associations in the hospital.

Access Information: Information [6].